Bazaar Updates
Closed · opens Mon 09:00 IST
Manage your watchlist and alerts here. Voting and comments need desktop.
Press ? for shortcuts
Report
Be the first to vote

CX Partners-backed Veeda Lifesciences eyes majority stake sale at upto $400 million valuation ↗

Veeda Lifesciences has restarted a process to sell a majority stake at a $300-400 million valuation, with existing investor CX Partners expected to exit and fresh capital aimed at expansion.

From Livemint Companies

Read full story ↗

Open on desktop to take part.

0 comments

Comments are posted by users and are not reviewed by Bazaar Updates.

Open on desktop to take part.

No comments yet.